NCT05139381View on ClinicalTrials.gov

Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab

Active, not recruitingOBSERVATIONAL

Enrollment

148

Participants

Timeline

Start Date

March 2, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 12, 2026

Conditions

Asthma in Children

Interventions

DRUG

Mepolizumab

Treatment with Mepoluzimab

Trial Locations (1)

SE5 9RS

King's College Hospital, London

All Listed Sponsors

lead

King's College Hospital NHS Trust

OTHER